0000899243-18-029744.txt : 20181128 0000899243-18-029744.hdr.sgml : 20181128 20181128164332 ACCESSION NUMBER: 0000899243-18-029744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181126 FILED AS OF DATE: 20181128 DATE AS OF CHANGE: 20181128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snodgres Jon CENTRAL INDEX KEY: 0001613498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 181206086 MAIL ADDRESS: STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET STREET 2: BUILDING #1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02435 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-26 0 0000730272 REPLIGEN CORP RGEN 0001613498 Snodgres Jon C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 CFO Common Stock 2018-11-26 4 M 0 11445 26.20 A 32344 D Common Stock 2018-11-26 4 M 0 4000 24.50 A 36344 D Common Stock 2018-11-26 4 M 0 6055 32.40 A 42399 D Common Stock 2018-11-26 4 M 0 10253 26.05 A 52652 D Common Stock 2018-11-26 4 S 0 31753 63.4874 D 20899 D Stock Option (Right to Buy) 26.20 2018-11-26 4 M 0 11445 0.00 D 2025-02-26 Common Stock 11445 0 D Stock Option (Right to Buy) 24.50 2018-11-26 4 M 0 4000 0.00 D 2024-07-14 Common Stock 4000 2000 D Stock Option (Right to Buy) 32.40 2018-11-26 4 M 0 6055 0.00 D 2027-02-23 Common Stock 6055 12110 D Stock Option (Right to Buy) 26.05 2018-11-26 4 M 0 10253 0.00 D 2026-02-26 Common Stock 10253 5127 D Sale of common stock was effective pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018. $63.4874 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.18 to $64.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is currently exercisable. 2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019. 6,055 shares vest and become exercisable on each of the following dates: 2/23/2018, 2/23/2019 and 2/23/2020. Shares vest and become exercisable as follows: 5,126 shares on 2/26/2017, 5,127 shares on 2/26/2018 and 5,127 shares on 2/26/2019. /s/ Jeffrey P. Leduc (Attorney in Fact) 2018-11-28